Cargando…
Commentary on “angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic”
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Diabetes India. Published by Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7380253/ https://www.ncbi.nlm.nih.gov/pubmed/32755842 http://dx.doi.org/10.1016/j.dsx.2020.07.041 |
| _version_ | 1783562816693731328 |
|---|---|
| author | Ferrario, Carlos M. |
| author_facet | Ferrario, Carlos M. |
| author_sort | Ferrario, Carlos M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7380253 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Diabetes India. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73802532020-07-24 Commentary on “angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic” Ferrario, Carlos M. Diabetes Metab Syndr Article Diabetes India. Published by Elsevier Ltd. 2020 2020-07-24 /pmc/articles/PMC7380253/ /pubmed/32755842 http://dx.doi.org/10.1016/j.dsx.2020.07.041 Text en © 2020 Diabetes India. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Ferrario, Carlos M. Commentary on “angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic” |
| title | Commentary on “angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic” |
| title_full | Commentary on “angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic” |
| title_fullStr | Commentary on “angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic” |
| title_full_unstemmed | Commentary on “angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic” |
| title_short | Commentary on “angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic” |
| title_sort | commentary on “angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during covid-19 pandemic” |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7380253/ https://www.ncbi.nlm.nih.gov/pubmed/32755842 http://dx.doi.org/10.1016/j.dsx.2020.07.041 |
| work_keys_str_mv | AT ferrariocarlosm commentaryonangiotensinconvertingenzymeinhibitorsandangiotensinreceptorblockersmaybeharmfulinpatientswithdiabetesduringcovid19pandemic |